JOHNSON AND JOHNSON FDA Approval NDA 021812

NDA 021812

JOHNSON AND JOHNSON

FDA Drug Application

Application #021812

Documents

Letter2006-05-24
Letter2014-03-04
Label2014-03-27
Label2015-02-17
Review2008-05-06
Letter2006-01-30
Letter2013-12-17
Letter2015-02-12
Label2006-01-27
Label2014-01-13
Letter2019-06-12
Label2019-06-17
Letter2020-02-04
Label2020-02-04
Letter2020-12-30
Label2021-01-07

Application Sponsors

NDA 021812JOHNSON AND JOHNSON

Marketing Status

Over-the-counter001
Over-the-counter002

Application Products

001AEROSOL, FOAM;TOPICAL5%1MEN'S ROGAINEMINOXIDIL
002AEROSOL, FOAM;TOPICAL5%1WOMEN'S ROGAINEMINOXIDIL

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2006-01-20STANDARD Label for Men's Rogaine
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2012-11-30STANDARD
EFFICACY; EfficacySUPPL9AP2014-02-28STANDARD Label for Women's Rogaine
LABELING; LabelingSUPPL10AP2013-12-13STANDARD Label for Men?s Rogaine
LABELING; LabelingSUPPL11AP2015-02-10STANDARD Label for Women?s Rogaine
LABELING; LabelingSUPPL14AP2019-06-11STANDARD Label for Women?s Rogaine
LABELING; LabelingSUPPL15AP2020-01-31STANDARD
LABELING; LabelingSUPPL16AP2020-12-29STANDARD

Submissions Property Types

SUPPL8Null0
SUPPL9Null15
SUPPL10Null6
SUPPL11Null6
SUPPL14Null7
SUPPL15Null15
SUPPL16Null6

CDER Filings

JOHNSON AND JOHNSON
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21812
            [companyName] => JOHNSON AND JOHNSON
            [docInserts] => ["",""]
            [products] => [{"drugName":"MEN'S ROGAINE","activeIngredients":"MINOXIDIL","strength":"5%","dosageForm":"AEROSOL, FOAM;TOPICAL","marketingStatus":"Over-the-counter","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"WOMEN'S ROGAINE","activeIngredients":"MINOXIDIL","strength":"5%","dosageForm":"AEROSOL, FOAM;TOPICAL","marketingStatus":"Over-the-counter","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"01\/31\/2020","submission":"SUPPL-15","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/021812s015lbl.pdf\"}]","notes":""},{"actionDate":"06\/11\/2019","submission":"SUPPL-14","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/021812Orig1s014lbl.pdf\"}]","notes":"Label for Women\u2019s Rogaine"},{"actionDate":"06\/11\/2019","submission":"SUPPL-14","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/021812Orig1s014lbl.pdf\"}]","notes":"Label for Women\u2019s Rogaine"},{"actionDate":"02\/10\/2015","submission":"SUPPL-11","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/021812Orig1s011lbl.pdf\"}]","notes":"Label for Women\u2019s Rogaine"},{"actionDate":"02\/28\/2014","submission":"SUPPL-9","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/021812Orig1s009lbl.pdf\"}]","notes":"Label for Women's Rogaine"},{"actionDate":"12\/13\/2013","submission":"SUPPL-10","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/021812Orig1s010lbl.pdf\"}]","notes":"Label for Men\u2019s Rogaine"},{"actionDate":"01\/20\/2006","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/021812s000LBL.pdf\"}]","notes":"Label for Men's Rogaine"}]
            [originalApprovals] => [{"actionDate":"MEN'S ROGAINE","submission":"MINOXIDIL","actionType":"5%","submissionClassification":"AEROSOL, FOAM;TOPICAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">Yes"},{"actionDate":"WOMEN'S ROGAINE","submission":"MINOXIDIL","actionType":"5%","submissionClassification":"AEROSOL, FOAM;TOPICAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2020-01-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.